HomeCompareOCDX vs MO

OCDX vs MO: Dividend Comparison 2026

OCDX yields 11.34% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MO wins by $35.4K in total portfolio value· pulled ahead in Year 8
10 years
OCDX
OCDX
● Live price
11.34%
Share price
$17.63
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.3K
Annual income
$2,306.36
Full OCDX calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — OCDX vs MO

📍 MO pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCDXMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCDX + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OCDX pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCDX
Annual income on $10K today (after 15% tax)
$964.27/yr
After 10yr DRIP, annual income (after tax)
$1,960.41/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, MO beats the other by $22,662.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCDX + MO for your $10,000?

OCDX: 50%MO: 50%
100% MO50/50100% OCDX
Portfolio after 10yr
$60.0K
Annual income
$15,637.45/yr
Blended yield
26.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

OCDX
No analyst data
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCDX buys
0
MO buys
0
No recent congressional trades found for OCDX or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCDXMO
Forward yield11.34%6.27%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$42.3K$77.7K
Annual income after 10y$2,306.36$28,968.54
Total dividends collected$17.1K$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: OCDX vs MO ($10,000, DRIP)

YearOCDX PortfolioOCDX Income/yrMO PortfolioMO Income/yrGap
1$11,834$1,134.43$10,558$768.31+$1.3KOCDX
2$13,918$1,254.70$11,352$1,015.87+$2.6KOCDX
3$16,271$1,379.03$12,482$1,367.86+$3.8KOCDX
4$18,916$1,506.73$14,103$1,883.39+$4.8KOCDX
5$21,878$1,637.13$16,472$2,664.91+$5.4KOCDX
6$25,179$1,769.55$20,024$3,897.79+$5.2KOCDX
7$28,845$1,903.31$25,537$5,933.74+$3.3KOCDX
8← crossover$32,901$2,037.77$34,478$9,476.77$1.6KMO
9$37,377$2,172.31$49,776$16,022.63$12.4KMO
10$42,300$2,306.36$77,699$28,968.54$35.4KMO

OCDX vs MO: Complete Analysis 2026

OCDXStock

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.

Full OCDX Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this OCDX vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCDX vs SCHDOCDX vs JEPIOCDX vs OOCDX vs KOOCDX vs MAINOCDX vs PMOCDX vs BTIOCDX vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.